Inhibitory activity of 3'-fluoro-2' deoxythymidine and related nucleoside analogues against adenoviruses in vitro

Antiviral Research

Volumn 34, Issue 3, 1997, Pages 113-119

  Mentel, R ^a   Kinder, M ^a   Wegner, U ^a   Von Janta Lipinski, M ^a   Matthes, E ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Adenovirus; Focus reduction assay; Inhibition of virus replication; Modified nucleoside analogues

Indexed keywords

2',3' DIDEOXYADENOSINE; 2',3' DIDEOXYGUANOSINE; 2',3' DIDEOXYTHYMIDINE; 3' FLUOROTHYMIDINE; LAMIVUDINE; NUCLEOSIDE ANALOG; STAVUDINE; VIRUS DNA; VIRUS PROTEIN; ZALCITABINE;

ADENOVIRUS; ADENOVIRUS 2; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; SEROTYPE; VIRUS REPLICATION;

EID: 0030902963     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)01029-2     Document Type: Article

References (27)

1. Baba, M., Mori, S., Shigeta, S. and De Clercq, E. (1987) Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2′-nor-cyclic GMP on adenovirus replication in vitro. Antimicrob. Agents Chemother. 31, 337–339.
2. Balzarini, J., Baba, M., Pauwels, R., Herdewijn, P., Wood, S.G., Robins, M.J. and DeClercq, E. (1988) Potent and selective activity of 3′-azido-2,6-diaminopurine-2′,3′-dideoxyriboside, 3′-fluoro-2,6-diaminopurine-2′,3′-dideoxyriboside, and 3′-fluoro-2′,3′-dideoxyguanosine against human immunodeficiency virus. Mol. Pharmacol. 33, 243–249.
3. Chu, C.K.V., Bhadti, S., Doboszewski, B., Gu, Z.G., Kosugi, Y., Pullaiah, K.C. and van Roey, P. (1989) General synthesis of 2′,3′-dideoxynucleosides and 2′,3′-didehydro-2′,3′-dideoxynucleosides. J. Org. Chem. 54, 2217–2225.
4. Cotton, M. and Weber, J.M. (1995) The adenovirus protease is required for virus entry into host cells. Virology 213, 494–502.
5. De Clercq, E. (1990) Selective virus inhibitors. Microbiologica 13, 165–178.
6. De Clercq, E. (1993) Antiviral agents: Characteristic activity spectrum depending on the molecular target with which they interact. In: Advances in Virus Research, Vol. 42, Academic Press, New York.
7. De Oliveira, C.B.R., Stevenson, D., La Bree, L., McDonnell, P.J. and Trousdale, M.D. (1996) Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res. 31, 165–172.
8. Gordon, Y.J., Romanowski, E., Araullo-Cruz, T., Seaberg, L., Erzurum, S., Tolman, R. and De Clercq, E. (1991) Inhibitory effect of (S)-HPMPC, (S)- HPMPA, and 2′-norcyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antiviral Res. 16, 11–16.
9. Hafkemeyer, P., Keppler-Hafkemeyer, A., Abo Al Haya, M., Janta-Lipinski, M., Matthes, E., Lehmann, C., Offensperger, W.-B., Offensperger, S., Gerok, W. and Blum, H.E. (1996) Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxy-3′-fluoroguanosine in vitro and in vivo. Antimicrob. Agents Chemother. 40, 792–794.
10. Herdewijn, P., van Aerschot, A. and Kerremans, L. (1989) Synthesis of nucleosides fluorinated in the sugar moiety. The application of diethylaminosulfurtrifluoride to the synthesis of fluorinated nucleosides. Nucleosides Nucleotides 8, 65–96.
11. Hui, M.B.V., Lien, E.J. and Trousdale, M.D. (1994) Inhibition of human adenoviruses by 1-(2′-hydroxy-5′-methoxybenzylidene) amino-3-hydroxyguanidine tosylate. Antiviral Res. 24, 261–273.
12. Jackson, R., Morris, D.J., Cooper, R.J., Bailey, A.S., Klapper, P.E., Cleator, G.M. and Tullo, A.B. (1996) Multiplex polymerase chain reaction for adenovirua and herpes simplex virus in eye swabs. J. Virol. Methods 56, 41–48.
13. Jernigan, J.A., Lowry, B.S., Hayden, F.G., Kyger, S.A., Conway, B.P., Gröschel, D.H.M. and Farr, B.M. (1993) Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J. Infect. Dis. 167, 1307–1313.
14. Kodama, E., Shigeta, S., Suzuki, T. and DeClercq, E. (1996) Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method. Antiviral Res. 31, 159–164.
15. Kowollik, G., Etzold, G., von Janta-Lipinski, M., Gaertner, K. and Langen, P. (1973) Ein neuer Zugang zu 1-(2,3-Dideoxy-3-fluor–D-ribofuranosyl)-pyrimidinen. J. Prakt. Chem. 315, 895–900.
16. Matsuse, T., Matsui, H., Shu, C.-Y, Nagase, T., Wakabayashi, T., Mori, S., Inoue, S., Fukuchi, Y. and Orimo, H. (1994) Adenovirus pulmonary infections identified by PCR and in situ hybridisation in bone marrow transplant recipients. J. Clin. Pathol. 47, 973–977.
17. Matthes, E., Lehmann, Ch., Scholz, D., von Janta-Lipinski, M., Gärtner, R., Rosenthal, H.A. and Langen, P. (1987) Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5′- triphosphate in comparison to cellular DNA polymerases α and β . Biochem. Biophys. Res. Commun. 148, 78–85.
18. Matthes, E., Lehmann, Ch., Scholz, D., Rosenthal, H.A. and Langen, P. (1988) Phosphorylation, anti-HIV activity and cytotoxicity of 3′-′- fluorothymidine. Biochem. Biophys. Res. Commun. 153, 825–831.
19. Matthes, E., Langen, P., von Janta-Lipinski, M., Will, H., Schröder, H.C., Merz, H., Weiler, B.E. and Müller, W.E.G. (1990) Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides. Antimicrob. Agents Chemother. 34, 1986–1990.
20. Matthes, E., Reimer, K., von Janta-Lipinski, M., Meisel, H. and Lehmann, C. (1991) Comparative inhibition of hepatitis B virus DNA polymerase and cellular DNA polymerases by triphosphates of sugar-modified 5′-methyldeoxycytidines and of other nucleoside analogs. Antimicrob. Agents Chemother. 35, 1254–1257.
21. Meisel, H., Reimer, K., von Janta-Lipinski, M., Bärwolff, D. and Matthes, E. (1990) Inhibition of hepatitis B-virus DNA-polymerase by 3′-fluorothymidine nucleoside triphosphate and other modified nucleoside triphosphate analogs. J. Med. Virol. 301, 137–141.
22. Mentel, R., Jacker, S. and Wegner, U. (1993) Studies on the development of an adenovirus infection model in hamsters. Hyg. Med. 18, 489–493.
23. Mentel, R., Matthes, E., von Janta-Lipinski, M. and Wegner, U. (1996) Fluorescent focus reduction assay for the screening of antiadenoviral agents. J. Virol. Methods 59, 99–104.
24. Schinazi, R.F., Mead, J.R. and Feorino, P.M. (1992) Insights into HIV chemotherapy. AIDS Res. Hum. Retrovir. 8, 963–990.
25. Suzuki, S., Lee, B., Luo, W., Robins, M.J. and Tyrrell, D.L.J. (1988) Inhibition of duck hepatitis B virus replication by purine 2′,3′-dideoxynucleosides. Biochem. Biophys. Res. Commun. 156, 1144–1151.
26. Van Aerschot, A., Herdewijn, P., Balzarini, J., Pauwels, R. and De Clercq, E. (1989) 3′-Fluoro-2′,3′-dideoxy-5-chlorouridine: Most selective anti-HIV-1 agent among a series of new 2′-and 3′-fluorinated 2′,3′-dideoxynucleoside analogues. J. Med. Chem. 32, 1743–1749.
27. Wold, W.S.M. and Gooding, L.R. (1991) Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184, 1–8.